These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5425552)

  • 1. Four regimens of streptomycin plus pyrazinamide in retreatment: East African-British Medical Research Council investigation.
    Stott H
    Bull Int Union Tuberc; 1970 Jun; 43():261-8. PubMed ID: 5425552
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis--second report. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
    Tubercle; 1970 Dec; 51(4):359-74. PubMed ID: 4924048
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-course (6-month) treatment of pulmonary tuberculosis (Second East African/British Medical Research Council Study).
    Jindani A
    Bull Int Union Tuberc; 1976; 51(1):53-6. PubMed ID: 71178
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa: second report. A co-operative study in East African and British Medical Research Councils.
    Tubercle; 1973 Dec; 54(4):283-90. PubMed ID: 4598425
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled comparison of four regimens of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis.
    Tubercle; 1969 Jun; 50(2):81-114. PubMed ID: 4892324
    [No Abstract]   [Full Text] [Related]  

  • 6. Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
    Allan WG
    Bull Int Union Tuberc; 1976; 51(1):91-3. PubMed ID: 1030317
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberxulisis in East Africa.
    Tubercle; 1971 Sep; 52(3):191-8. PubMed ID: 4938216
    [No Abstract]   [Full Text] [Related]  

  • 8. Hong Kong Tuberculosis Treatment Services/British Medical Research Council study of short-course regimens of streptomycin, isoniazid and pyrazinamide: latest results.
    Girling DJ
    Tubercle; 1975 Jun; 56(2):165-6. PubMed ID: 1181689
    [No Abstract]   [Full Text] [Related]  

  • 9. Streptomycin plus pas plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa.
    East Afr Med J; 1972 Jan; 49(1):7-15. PubMed ID: 4555041
    [No Abstract]   [Full Text] [Related]  

  • 10. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
    Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled clinical trial of streptomycin plus thiacetazone: British Medica Research Council-Rhodesian Tuberculosis Service-Brompton Hospital laboratory investigation.
    Shennan DH
    Tubercle; 1968 Mar; 49():Suppl:26-8. PubMed ID: 4173323
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 15. Three initial streptomycin supplements to standard isoniazid-thiacetazone chemotherapy. East African-British Medical Research Council investigation.
    Kent PW
    Bull Int Union Tuberc; 1970 Jun; 43():256-60. PubMed ID: 4193294
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 17. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of 2 intermittent therapeutic regimens: ethionamide-isoniazid and streptomycin-isoniazid].
    Lahlou M
    Bull Int Union Tuberc; 1970 Jun; 43():289-94. PubMed ID: 5425557
    [No Abstract]   [Full Text] [Related]  

  • 20. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.